Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Universal vaccination of children against influenza: are there indirect benefits to the community? A systematic review of the evidence.

Jordan R, Connock M, Albon E, Fry-Smith A, Olowokure B, Hawker J, Burls A.

Vaccine. 2006 Feb 20;24(8):1047-62. Epub 2005 Sep 26. Review.

PMID:
16298026
2.
3.

Pharmacoeconomics of influenza vaccination for healthy working adults: reviewing the available evidence.

Postma MJ, Jansema P, van Genugten ML, Heijnen ML, Jager JC, de Jong-van den Berg LT.

Drugs. 2002;62(7):1013-24. Review.

PMID:
11985488
4.

Economic evidence of influenza vaccination in children.

Savidan E, Chevat C, Marsh G.

Health Policy. 2008 May;86(2-3):142-52. Epub 2007 Dec 3. Review.

PMID:
18054109
5.

Health benefits, risks, and cost-effectiveness of influenza vaccination in children.

Fleming DM, Elliot AJ.

Pediatr Infect Dis J. 2008 Nov;27(11 Suppl):S154-8. doi: 10.1097/INF.0b013e31818a5443.

PMID:
18955891
6.

Cost-effectiveness of influenza vaccination of healthy children.

Salo H, Kilpi T, Sintonen H, Linna M, Peltola V, Heikkinen T.

Vaccine. 2006 Jun 5;24(23):4934-41. Epub 2006 Apr 7.

PMID:
16678945
7.
8.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

9.

Economic benefits for the family of inactivated subunit virosomal influenza vaccination of healthy children aged 3-14 years during the annual health examination in private paediatric offices.

Salleras L, Navas E, Domínguez A, Ibáñez D, Prat A, Garrido P, Asenjo MA, Torner N.

Vaccine. 2009 May 26;27(25-26):3454-8. doi: 10.1016/j.vaccine.2009.01.053. Epub 2009 Feb 5.

PMID:
19200830
10.

Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3-14 years from the provider and societal perspectives.

Navas E, Salleras L, Domínguez A, Ibáñez D, Prat A, Sentís J, Garrido P.

Vaccine. 2007 Apr 20;25(16):3233-9. Epub 2007 Jan 25.

PMID:
17324489
11.

Physical interventions and injection techniques for reducing injection pain during routine childhood immunizations: systematic review of randomized controlled trials and quasi-randomized controlled trials.

Taddio A, Ilersich AL, Ipp M, Kikuta A, Shah V; HELPinKIDS Team..

Clin Ther. 2009;31 Suppl 2:S48-76. doi: 10.1016/j.clinthera.2009.07.024. Review.

PMID:
19781436
12.

Estimating the impact of childhood influenza vaccination programmes in England and Wales.

Vynnycky E, Pitman R, Siddiqui R, Gay N, Edmunds WJ.

Vaccine. 2008 Sep 26;26(41):5321-30. doi: 10.1016/j.vaccine.2008.06.101. Epub 2008 Jul 21.

PMID:
18647634
13.

Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review.

Bryant J, Picot J, Levitt G, Sullivan I, Baxter L, Clegg A.

Health Technol Assess. 2007 Jul;11(27):iii, ix-x, 1-84. Review.

14.

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.

King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R.

Health Technol Assess. 2006 Jul;10(23):iii-iv, xiii-146. Review.

15.

Cost-effectiveness of adjuvanted influenza vaccination of healthy children 6 to 60 months of age.

Marchetti M, Kühnel UM, Colombo GL, Esposito S, Principi N.

Hum Vaccin. 2007 Jan-Feb;3(1):14-22. Epub 2007 Jan 29.

PMID:
17245134
16.

Cost effectiveness of influenza vaccination in older adults: a critical review of economic evaluations for the 50- to 64-year age group.

Newall AT, Kelly H, Harsley S, Scuffham PA.

Pharmacoeconomics. 2009;27(6):439-50. doi: 10.2165/00019053-200927060-00001. Review.

PMID:
19640008
17.

Universal influenza vaccination and live attenuated influenza vaccination of children.

Glezen WP.

Pediatr Infect Dis J. 2008 Oct;27(10 Suppl):S104-9. doi: 10.1097/INF.0b013e318168b729.

PMID:
18820568
18.

[Assessment of efficacy and economic impact of an influenza vaccination campaign in the personnel of a health care setting].

Cella MT, Corona G, Tuccillo E, Franco G.

Med Lav. 2005 Nov-Dec;96(6):483-9. Italian.

PMID:
16983973
19.

The effectiveness and cost-effectiveness of parent training/education programmes for the treatment of conduct disorder, including oppositional defiant disorder, in children.

Dretzke J, Frew E, Davenport C, Barlow J, Stewart-Brown S, Sandercock J, Bayliss S, Raftery J, Hyde C, Taylor R.

Health Technol Assess. 2005 Dec;9(50):iii, ix-x, 1-233. Review.

20.

Influenza vaccination coverage among children with high-risk medical conditions.

Esposito S, Marchisio P, Droghetti R, Lambertini L, Faelli N, Bosis S, Tosi S, Begliatti E, Principi N.

Vaccine. 2006 Jun 12;24(24):5251-5. Epub 2006 Mar 31.

PMID:
16621177

Supplemental Content

Support Center